2025 annual financial data
Dogwood Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -27,968,445 USD and net income was -34,257,370 USD.
Operating cash flow was -15,618,651 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,968,445 USD
- Net income
- -34,257,370 USD
- Operating cash flow
- -15,618,651 USD